ARCH Venture Partners raises $400m

The US firm has raised $400 million for its seventh fund, to focus on early stage investments in biotechnology, advanced materials and specialty semiconductors.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this